Table 2. Treatment efficacy of the patients.
| Clinical and pathological response | Cases (%) |
|---|---|
| Clinical response | |
| Stable disease | 11 (34.4) |
| Progressive disease | 0 |
| Partial response | 21 (65.6) |
| Surgical procedure | |
| Proximal gastrectomy | 2 (6.3) |
| Distal gastrectomy | 23 (71.9) |
| Total gastrectomy | 7 (21.9) |
| Residual tumor classification | |
| R0 | 30 (93.8) |
| R1/2 | 2 (6.3) |
| Extent of lymphadenectomy | |
| D0–1 | 2 (6.3) |
| D2 | 12 (37.5) |
| D2+PAND | 18 (56.3) |
| TRG | |
| 0 | 7 (21.9) |
| 1 | 13 (40.6) |
| 2 | 5 (15.6) |
| 3 | 7 (21.9) |
PAND, para-aortic lymph node dissection; TRG, tumor regression grade.